Scrip World Pharmaceutical News has published the 2009 edition of the Scrip 100 - its flagship annual analysis of the pharmaceutical industry. The 2009 edition of the Scrip 100 provides data, research and expert opinion on the performance, prospects and current state of the biopharmaceuticals market.
Published by Informa Pharma, the Scrip 100 provides an insightful encapsulation of the pharma industry as the sector's major players prepare for the challenges of the year ahead. The 2009 edition of the Scrip 100 mirrors the structure of the recently relaunched Scrip news and analysis service - with chapters devoted to business issues, developments in R&D, policy and regulation, the clinical trials landscape and opportunities presented by the world's emerging markets.
Highlights of the latest edition of Scrip 100 include the biopharmaceutical sector's top 100 companies ranking; an interview with Fred Hassan on why he shunned early retirement in favour of transforming the fortunes of Schering-Plough; and the Scrip stock tracker - a look at the robustness of the pharma business model in light of extreme market volatility in 2008. In addition, the Scrip 100 takes a close look at why oncology continues to capture the industry's imagination, and also outlines 2008 NME approvals in the US, Europe and Japan.
